TLR9 agonist SD-101
Term · Oncology and biomedicine · MLC-T-ONC-017213
A proprietary oligonucleotide with immunostimulatory activity. Immunostimulatory phosphorothiolate oligodeoxyribonucleotide SD-101 targets Toll-Like Receptor 9 (TLR9) found on a specialized subset of dendritic cells. The interaction of TLR9 with SD-101, in conjunction with an allergen or antigen, induces activation of memory T helper cells 1 (Th1) against a specific pathogen or allergen, thereby leading to long-lasting therapeutic effects. Furthermore, this agent does not cause a generalized activation of the immune system.
| Identifier | MLC-T-ONC-017213 |
|---|---|
| Field | Oncology and biomedicine |
| Abbreviation | ISS-ODN SD-101 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-017213",
"term": "TLR9 agonist SD-101",
"field": "Oncology and biomedicine",
"definition": "A proprietary oligonucleotide with immunostimulatory activity. Immunostimulatory phosphorothiolate oligodeoxyribonucleotide SD-101 targets Toll-Like Receptor 9 (TLR9) found on a specialized subset of dendritic cells. The interaction of TLR9 with SD-101, in conjunction with an allergen or antigen, induces activation of memory T helper cells 1 (Th1) against a specific pathogen or allergen, thereby leading to long-lasting therapeutic effects. Furthermore, this agent does not cause a generalized activation of the immune system.",
"abbreviation": "ISS-ODN SD-101",
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/tlr9-agonist-sd-101/"
}
Record 16,433 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.